drugset
drugset / Trial / NCT01340521

Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH) Response to Low Dose Clomiphene Citrate in Normally Menstruating Fertile Women

NCT01340521 ↗

Phase 1/2 Completed 25 enrolled Milton S. Hershey Medical Center Mayo Clinic · collab
NaSingle-groupOpen-labelTreatment

Summary

The goal of the study is to quantitatively evaluate pituitary hormone response, follicle stimulating hormone (FSH) and luteinizing hormone (LH), to low doses of clomiphene citrate in normally fertile women.

Timeline

Start
1991-03
Primary completion
1994-03
Completion
1994-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Clomiphene Other / unclassified 25 mg Oral
Subject Clomiphene Other / unclassified 50 mg Oral
Subject Clomiphene Other / unclassified 100 mg Oral

Indications

infertility disorder